Halbert Christine L, Allen James M, Chamberlain Jeffrey S
Department of Neurology, Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Washington, Seattle, WA, 98195-7720, USA.
Methods Mol Biol. 2018;1687:257-266. doi: 10.1007/978-1-4939-7374-3_18.
Vectors derived from adeno-associated viruses (AAV) have been generated using numerous naturally occurring and synthetic serotypes of the virus. Such vectors have proven to be extremely useful for a variety of gene transfer studies, both in vitro and in vivo, and are increasingly being used in gene therapy protocols for a variety of human disorders. Methods to produce AAV vectors typically rely on co-transfection of several different plasmid vectors that carry the transgene of interest (the gene to be delivered , in a "transfer plasmid") and helper genes needed for AAV vector replication and packaging (helper plasmids). While the methods used to generate AAV are conceptually simple, minor variations in a variety of steps can result in significant differences in the overall yield of vector. Here we describe protocols for generating vectors derived from AAV6, which are particularly useful for gene transfer to muscle tissues.
源自腺相关病毒(AAV)的载体已利用该病毒的多种天然存在的和合成的血清型构建而成。这类载体已被证明在体外和体内的各种基因转移研究中极为有用,并且越来越多地被用于针对各种人类疾病的基因治疗方案中。生产AAV载体的方法通常依赖于共转染几种不同的质粒载体,这些质粒载体携带感兴趣的转基因(待递送的基因,存在于“转移质粒”中)以及AAV载体复制和包装所需的辅助基因(辅助质粒)。虽然用于生成AAV的方法在概念上很简单,但各个步骤中的微小差异可能会导致载体总产量的显著差异。在此,我们描述了生成源自AAV6的载体的方案,这些载体对于将基因转移到肌肉组织特别有用。